The ESSENCE of hope: what semaglutide’s Food and Drug Administration approval means for metabolic dysfunction-associated steatohepatitis
All content on this site: Copyright © 2026 AME Publishing Company. All rights are reserved. For all open access content, the Creative Commons licensing terms apply.
Published by AME Publishing Company
Address: Flat/RM C 16F, Kings Wing Plaza 1, NO. 3 on Kwan Street, Shatin, NT, Hong Kong, China.
Email: editor@thehbsn.org
Comments (0)